Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/235468
Type: Artigo de periódico
Title: The Immunomodulation To Diabetes Control: New Proposals For The Reversion Of This Disease.
Author: Mâncio, Rafael Dias
Minatel, Elaine
de Almeida Cardoso, Maurício
Ali Khan, Barkat
José Caldeira, Eduardo
Abstract: The diabetes mellitus is a metabolic disorder, characterized by the hyperglycemia with deficiency in the use of carbohydrates, fats and proteins, resultant of the impairment in secretion and/or insulin action. Severely, the type 1 diabetes provokes the compromise of several organs, causing different disorders and until death of patient. In this way, the literature has shown the general treatments for the type 1 diabetes and currently the focus in immunotherapy and/or immunomodulation, to control of this hyperglycemic condition. The use of new therapies is necessary due to the high increase of incidence of this disease around the world. Recent studies showed an increase of 40% in the cases since 1997. This disease affects different organs, including the glandular tissues, mainly the pancreas. Despite all therapies for diabetes control, the damages occurred remain irreversible. Thus, in addition to general treatments, the use of immunotherapy may open new perspectives for treatment of this disease. Within this aspect, the anti-CD3 monoclonal antibodies may be effective, mainly by protect and maintain the pancreatic acinar cells. Thus, these treatments based in the immunomodulation can be an option for diabetes control and to reverse the damage caused by this disease.
Subject: Antigen–antibody Complex
Diabetes Mellitus
Immunotherapy
Treatment
Type 1
Rights: embargo
Identifier DOI: 10.1016/j.dsx.2015.08.003
Address: http://www.ncbi.nlm.nih.gov/pubmed/?term=26321040
Date Issue: -1-Uns- -1
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_26321040.pdf202.58 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.